Allianz Asset Management’s Boston Scientific BSX Stock Holding History

Allianz Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.4M	Buy	86,100 +20,400	+31%	+$1.63M	0.01%	1133
2025 Q4	$6.26M	Buy	65,700 +36,900	+128%	+$3.62M	0.01%	1024
2025 Q3	$2.81M	Sell	28,800 -59,300	-67%	-$6.14M	﹤0.01%	1363
2025 Q2	$9.46M	Buy	88,100 +16,500	+23%	+$1.67M	0.01%	836
2025 Q1	$7.22M	Buy	71,600 +19,400	+37%	+$1.95M	0.01%	925
2024 Q4	$4.66M	Buy	52,200 +6,100	+13%	+$537K	0.01%	1082
2024 Q3	$3.86M	Buy	46,100 +26,300	+133%	+$2.07M	0.01%	1167
2024 Q2	$1.52M	Sell	19,800 -27,400	-58%	-$2.01M	﹤0.01%	1418
2024 Q1	$3.23M	Sell	47,200 -101,900	-68%	-$6.55M	0.01%	1023
2023 Q4	$8.62M	Sell	149,100 -28,300	-16%	-$1.51M	0.01%	730
2023 Q3	$9.37M	Buy	177,400 +108,400	+157%	+$5.69M	0.02%	744
2023 Q2	$3.73M	Buy	69,000 +26,600	+63%	+$1.39M	0.01%	981
2023 Q1	$2.12M	Buy	42,400 +23,200	+121%	+$1.09M	﹤0.01%	1361
2022 Q4	$888K	Buy	19,200 +15,200	+380%	+$658K	﹤0.01%	1559
2022 Q3	$155K	Sell	4,000 -8,000	-67%	-$321K	﹤0.01%	1647
2022 Q2	$447K	Sell	12,000 -54,700	-82%	-$2.23M	﹤0.01%	1920
2022 Q1	$2.95M	Buy	66,700 +11,000	+20%	+$477K	﹤0.01%	1447
2021 Q4	$2.37M	Sell	55,700 -27,200	-33%	-$1.14M	﹤0.01%	1544
2021 Q3	$3.6M	Buy	82,900 +59,300	+251%	+$2.62M	﹤0.01%	1420
2021 Q2	$1.01M	Sell	23,600 -3,300	-12%	-$139K	﹤0.01%	1740
2021 Q1	$1.04M	Buy	+26,900	New	+$1.02M	﹤0.01%	1626
2020 Q4	–	Sell	-30,100	Closed	-$1.15M	–	1855
2020 Q3	$1.15M	Sell	30,100 -85,800	-74%	-$3.31M	﹤0.01%	1392
2020 Q2	$4.07M	Buy	115,900 +43,700	+61%	+$1.57M	﹤0.01%	1301
2020 Q1	$2.36M	Sell	72,200 -195,800	-73%	-$7.65M	﹤0.01%	1470
2019 Q4	$12.1M	Buy	268,000 +18,700	+8%	+$782K	0.01%	1029
2019 Q3	$10.1M	Sell	249,300 -26,600	-10%	-$1.13M	0.01%	1106
2019 Q2	$11.9M	Buy	275,900 +166,600	+152%	+$6.41M	0.01%	1106
2019 Q1	$4.2M	Sell	109,300 -247,700	-69%	-$9.46M	﹤0.01%	1541
2018 Q4	$12.6M	Sell	357,000 -59,200	-14%	-$2.15M	0.01%	991
2018 Q3	$16M	Sell	416,200 -69,300	-14%	-$2.42M	0.01%	1017
2018 Q2	$15.9M	Buy	485,500 +37,400	+8%	+$1.13M	0.02%	1006
2018 Q1	$12.2M	Sell	448,100 -273,000	-38%	-$7.42M	0.01%	1157
2017 Q4	$17.9M	Buy	721,100 +72,300	+11%	+$1.99M	0.01%	1036
2017 Q3	$18.9M	Buy	648,800 +120,900	+23%	+$3.34M	0.02%	989
2017 Q2	$14.6M	Buy	527,900 +18,400	+4%	+$488K	0.01%	1137
2017 Q1	$12.7M	Sell	509,500 -313,100	-38%	-$7.61M	0.01%	1231
2016 Q4	$17.8M	Buy	822,600 +212,700	+35%	+$4.64M	0.02%	1074
2016 Q3	$14.5M	Buy	609,900 +45,800	+8%	+$1.09M	0.01%	1145
2016 Q2	$13.2M	Buy	564,100 +112,300	+25%	+$2.43M	0.01%	1107
2016 Q1	$8.5M	Buy	451,800 +214,900	+91%	+$3.77M	0.01%	1222
2015 Q4	$4.37M	Buy	236,900 +53,300	+29%	+$955K	﹤0.01%	1412
2015 Q3	$3.01M	Sell	183,600 -28,000	-13%	-$479K	﹤0.01%	1463
2015 Q2	$3.75M	Buy	211,600 +75,700	+56%	+$1.35M	﹤0.01%	1477
2015 Q1	$2.41M	Buy	+135,900	New	+$2.15M	﹤0.01%	1465

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Allianz Asset Management's BSX Position: Q1 2026 in Review

Allianz Asset Management increased its Boston Scientific (BSX) stake by 20% in Q1 2026, buying an estimated $31.5M and bringing the position to 2,393,824 shares worth $150M. The position accounts for 0.16% of the portfolio, ranked #126.

Allianz Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $363M in Q2 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Allianz Asset Management held 2,393,824 shares of Boston Scientific worth $150M as of Q1 2026.
Allianz Asset Management bought 394,232 Boston Scientific shares in Q1 2026, an estimated $31.5M.
Boston Scientific made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #126 holding.
Allianz Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
Allianz Asset Management's Boston Scientific position peaked at $363M in Q2 2019.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.